Cargando…
Should leptin replace insulin as a lifetime monotherapy for diabetes type 1 and 2?
Evidence accumulated during the last decade has affirmed that adipocyte leptin insufficiency in the hypothalamus is the primary etiological factor in the pathogenesis of diabetes type 1 and 2 and related metabolic morbidities. Leptin insufficiency disrupts the relay of hypothalamic regulatory inform...
Autor principal: | Kalra, Satya P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830314/ https://www.ncbi.nlm.nih.gov/pubmed/24251168 http://dx.doi.org/10.4103/2230-8210.119496 |
Ejemplares similares
-
A case for new therapy for diabetes, is it leptin?
por: Kalra, Satya P.
Publicado: (2012) -
Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir
por: Olczyk, Paweł, et al.
Publicado: (2017) -
Insulin in Type 1 and Type 2 Diabetes—Should the Dose of Insulin Before a Meal be Based on Glycemia or Meal Content?
por: Krzymien, Janusz, et al.
Publicado: (2019) -
Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017) -
Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)